Stay updated on Genetically Engineered NY-ESO-1ᶜ²⁵⁹T Clinical Trial
Sign up to get notified when there's something new on the Genetically Engineered NY-ESO-1ᶜ²⁵⁹T Clinical Trial page.

Latest updates to the Genetically Engineered NY-ESO-1ᶜ²⁵⁹T Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe web page has undergone significant content removal, particularly regarding the details of a clinical trial for NY-ESO-1 specific T cells in patients with synovial sarcoma, including patient eligibility criteria and treatment protocols. Additionally, the version number has been updated from v2.14.4 to v2.15.0.SummaryDifference22%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.8%
- Check88 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference0.9%
Stay in the know with updates to Genetically Engineered NY-ESO-1ᶜ²⁵⁹T Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Genetically Engineered NY-ESO-1ᶜ²⁵⁹T Clinical Trial page.